Importantly, staining of adjacent tumor sections with antibodies to β-catenin revealed that LBH was expressed in a subset of invasive CRC cells with nuclear β-catenin expression (Fig. 7B), which is a hallmark of WNT activation [45]. The gene discussed is LBH; the disease is neoplasm.